Olmecast Trio 20mg/5mg/12.5mg Tablet

Overview Olmecast Trio 20mg/5mg/12.5mg Tablet

HCTZ-Olmesartan-Amlodipine 20mg/5mg/12.5mg tablets are a triple-drug formulation for managing hypertension unresponsive to monotherapy. This combination lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. These tablets may be taken with or without food; dosage is individualized and should be taken consistently at the same time daily, as directed by your physician. Continued use is crucial, even with symptom absence, as hypertension is often asymptomatic. Discontinuation increases stroke and heart attack risk. The medication includes a diuretic, potentially increasing urination; therefore, avoid dosing within four hours of bedtime. Common side effects include fatigue, altered taste, dizziness, headache, and edema. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential dehydration symptoms like thirst, dry mouth, and muscle weakness. Prior to commencing treatment, inform your doctor about existing kidney or liver conditions, pregnancy, breastfeeding, or any other medications being used, particularly those for heart conditions or hypertension. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to assess treatment efficacy.

Primary Ingredients of Olmecast Trio 20mg/5mg/12.5mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Olmecast Trio 20mg/5mg/12.5mg Tablet

Elevated arterial blood pressure

Major Benefits of Olmecast Trio 20mg/5mg/12.5mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmecast Trio 20mg/5mg/12.5mg Tablets can be administered with or without food, although consistent timing is recommended for optimal results.

Common Side effects of Olmecast Trio 20mg/5mg/12.5mg Tablet:

• Headache
• Dizziness
• Nausea
• Upper respiratory tract infection
• Fatigue
• Urinary tract infection
• Diarrhea
• Joint swelling
• Peripheral edema
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Muscle spasm
• Hypotension (low blood pressure)
• Increased creatinine level in blood
• Increased blood urea
• Increased uric acid level in blood

How to use Olmecast Trio 20mg/5mg/12.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Olmecast Trio 20mg/5mg/12.5mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, however, consistent daily timing is recommended.

How Olmecast Trio 20mg/5mg/12.5mg Tablet works:

Olmecast Trio tablets (20mg/5mg/12.5mg) contain olmesartan medoxomil, amlodipine, and hydrochlorothiazide, each serving a distinct role in blood pressure management. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, collaboratively dilate blood vessels, reducing vascular resistance and lowering blood pressure. Hydrochlorothiazide, a diuretic, facilitates the excretion of excess fluid and electrolytes, contributing to lowered blood pressure through both diuresis and vasodilation.

What if you forget to take Olmecast Trio 20mg/5mg/12.5mg Tablet :

Should you forget to take your Olmecast Trio 20mg/5mg/12.5mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.